Zacks Research Issues Negative Forecast for CVSA Earnings

Key Points

• Zacks Research lowered Adtalem Global Education’s Q1 2027 EPS estimate to $1.97 from $2.00, while the company’s FY 2027 guidance remains $8.90–$9.15 per share.
• Adtalem recently reported quarterly EPS of $2.09, beating consensus by $0.19, on revenue of $501.38 million. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $155.
• CVSA shares opened at $128.38 after declining 2.7%; institutional investors own 98.84% of the stock, while company insiders sold approximately $3.47 million of shares during the past quarter.

Adtalem Global Education Inc. (NYSE:CVSA - Free Report) - Stock analysts at Zacks Research cut their Q1 2027 earnings per share estimates for Adtalem Global Education in a report released on Thursday, August 20th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.97 per share for the quarter, down from their prior estimate of $2.00. The consensus estimate for Adtalem Global Education's current full-year earnings is $8.99 per share. Zacks Research also issued estimates for Adtalem Global Education's Q2 2027 earnings at $2.38 EPS, Q4 2027 earnings at $2.28 EPS, Q1 2028 earnings at $2.30 EPS, Q2 2028 earnings at $2.56 EPS, Q3 2028 earnings at $2.50 EPS, Q4 2028 earnings at $2.59 EPS, FY2028 earnings at $9.94 EPS and FY2029 earnings at $11.53 EPS.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.19. The firm had revenue of $501.38 million for the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS.

CVSA has been the topic of a number of other research reports. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Adtalem Global Education in a research report on Wednesday. Barrington Research reaffirmed an "outperform" rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial boosted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, May 11th. Finally, Wall Street Zen raised shares of Adtalem Global Education from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $155.00.

Adtalem Global Education Stock Down 2.7%

Shares of CVSA opened at $128.38 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The stock has a market cap of $4.37 billion, a P/E ratio of 18.24, a P/E/G ratio of 0.98 and a beta of 0.62. The business's 50 day simple moving average is $125.46.

Institutional Trading of Adtalem Global Education

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management acquired a new stake in Adtalem Global Education Inc. (NYSE:CVSA - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,622 shares of the company's stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors.

Insider Activity at Adtalem Global Education

In other Adtalem Global Education news, CFO Robert J. Phelan sold 2,900 shares of the firm's stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $135.41, for a total value of $392,689.00. Following the transaction, the chief financial officer directly owned 52,906 shares of the company's stock, valued at $7,164,001.46. This trade represents a 5.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 4,526 shares of the business's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $135.81, for a total value of $614,676.06. Following the transaction, the senior vice president owned 28,544 shares in the company, valued at approximately $3,876,560.64. This represents a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 25,951 shares of company stock worth $3,470,783. Company insiders own 2.50% of the company's stock.

Adtalem Global Education Company Profile

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source